Registrational Section III Research of APG-2449 Cleared by China CDE for the Therapy of Sufferers with NSCLC By Investing.com
ROCKVILLE, Md. and SUZHOU, China, Oct. 7, 2024 /PRNewswire/ -- Ascentage Pharma…
Research outcomes from section 1 research with exidavnemab printed in The Journal of Medical Pharmacology By Investing.com
STOCKHOLM, Aug. 27, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA…
